Rainer M. Erdtmann is Sr. VP & IR and Admin at PHARMACYCLICS INC (PCYC). They have made 9 open-market trades across 3 companies since 2012, most recently 2025-12-11.
CIK 0001455767
6 open-market purchases totalling $1.0M since 2018, against 3 sales. Across 6 scored buys the stock is up 37.0% at ninety days, and 37.3 points ahead of the S&P over the same stretch.
6 scored purchases · one row per filing · discretionary only
| Ticker | Shares | Value |
|---|---|---|
| BMEA | 723,027 | $631K |
| PTE | 30,000 | $7K |
| PCYC | 5,701 | — |
| Total | $638K |
Shares reported on the most recent Form 4, priced at the 2025-12-15 close. 1 holding could not be priced and is excluded from the total.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 83% | 50% | 50% |
| Avg Move | +14.5% | +6.2% | +37.0% |
| Alpha | +14.0% | +8.1% | +37.3% |
| Scored | 6 | 6 | 6 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| BMEA | BUY | 2025-12-11 | 2025-12-15 | $1.43 | $43K | -3.6% | +18.2% | -8.8% |
| BMEA | BUY | 2025-11-28 | 2025-12-02 | $1.09 | $55K | +41.0% | +34.0% | +37.0% |
| BMEA | BUY | 2021-08-23 | 2021-08-25 | $13.20 | $317K | +6.6% | -16.6% | -13.2% |
| BMEA | BUY | 2021-08-17 | 2021-08-19 | $10.78 | $302K | +28.7% | -4.5% | +7.7% |
| BMEA | BUY | 2021-04-15 | 2023-02-10 | $17.00 | $92K | +9.7% | +39.8% | +220.0% |
| PTE | SELL | 2019-12-16 | 2019-12-17 | $2.47 | $157K | +0.4% | +72.0% | -63.3% |
| PTE | BUY | 2018-09-14 | 2018-09-18 | $17.42 | $233K | +4.9% | -33.5% | -20.6% |
| PCYC | SELL | 2013-12-13 | 2013-12-16 | $107.78 | $5.8M | N/A | N/A | N/A |
| PCYC | SELL | 2012-12-17 | 2012-12-18 | $62.57 | $5.9M | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.